Action Nervgen Pharma - NGEN

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Dernier

2,93

Prix Achat

2,90

Prix Vente

2,93

Volume échangé

54 065

2,90 Fourchette du Jour 3,04

0,00 Plage de 52 semaines 0,00

Cap du marché

174,646M

Clôture Veille

2,95

Ouverture

2,97

Dernière Transaction

400

2.93

Dernière heure de transaction

Volume financier

VWAP

Volume moyen (3 m)

Actions en circulation

59 606 000

Rendement du Dividende

Ratio Cours sur Bénéfices

-7,80

Bénéfice par action (BPA)

-0,38

Chiffre d'affairess

Bénéfice net

-22,38M

Secteur

Pharmaceutical Preparations

Industrie

Pharmaceutical Preparations

Site Web

nervgen.com/

Siège social

Vancouver, British Columbia, Can

Fondé

Nervgen Pharma Corporation est coté dans le secteur Pharmaceutical Preparations de la TSX Venture Exchange avec le ticker NGEN. Le dernier cours de clôture d'Nervgen Pharma était de $2,95. Au cours de la dernière année, les actions de Nervgen Pharma ont été négociées dans une fourchette de prix de $ 0,00 à $ 0,00.

Nervgen Pharma compte actuellement 59 606 000 actions en circulation. La capitalisation boursière d'Nervgen Pharma est de $175,84 million. Nervgen Pharma a un ratio cours/bénéfice (ratio PE) de -7.80.

Life Science Investor Forum Agenda Announced for June 22nd

NEW YORK, June 20, 2023 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the Life Science Investor Forum...

NervGen Pharma’s NVG-291-R Demonstrates Significant Functional Repair From a Stroke 7 Days After Onset in Landmark Preclinical Study by University of Cincinnati and Case Western Reserve University

The independent peer-reviewed study showed improved memory as well as motor and sensory functions in rodents when treatment with NVG-291-R began 7 days after stroke onset There is currently no...

NervGen Pharma Announces Intent to Conduct Groundbreaking Spinal Cord Injury Clinical Trial in Exclusive Partnership With Shirley Ryan AbilityLab, #1-Ranked Hospital in Physical Medicine & Rehabilitation

Phase 1b/2a trial of NervGen’s lead compound, NVG-291, is based upon unprecedented, peer-reviewed animal studies demonstrating pronounced functional recovery from spinal cord injury “The ability...

NervGen Pharma Corp. Announces Public Offering

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, July 22, 2020 (GLOBE NEWSWIRE) -- NervGen Pharma Corp. (TSX-V: NGEN; OTCQX:...

American Stock Exchange to Trade Options on Four Securities

American Stock Exchange to Trade Options on Four Securities NEW YORK, Jan. 9 /PRNewswire/ -- The American Stock Exchange(R) (Amex(R)) will launch trading in options on Monday, January 12, 2004...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

NGEN - Frequently Asked Questions (FAQ)

What is the current Nervgen Pharma share price?

The current share price of Nervgen Pharma is $ 2,93

How many Nervgen Pharma shares are in issue?

Nervgen Pharma has 59 606 000 shares in issue

What is the market cap of Nervgen Pharma?

The market capitalisation of Nervgen Pharma is CAD 175,84M

What is the 1 year trading range for Nervgen Pharma share price?

Nervgen Pharma has traded in the range of $ 0,00 to $ 0,00 during the past year

What is the PE ratio of Nervgen Pharma?

The price to earnings ratio of Nervgen Pharma is -7,8

What is the reporting currency for Nervgen Pharma?

Nervgen Pharma reports financial results in CAD

What is the latest annual profit for Nervgen Pharma?

The latest annual profit of Nervgen Pharma is CAD -22,38M

What is the registered address of Nervgen Pharma?

The registered address for Nervgen Pharma is 1133 MELVILLE STREET, SUITE 3500, THE STACK, VANCOUVER, BRITISH COLUMBIA, V6E 4E5

What is the Nervgen Pharma website address?

The website address for Nervgen Pharma is nervgen.com/

Which industry sector does Nervgen Pharma operate in?

Nervgen Pharma operates in the PHARMACEUTICAL PREPARATIONS sector

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
AHRAmarc Resources Ltd	$ 0,72 (171,70%)	4,17M
OEG.HONEnergy Inc	$ 0,035 (133,33%)	14,66k
FYLFinlay Minerals Ltd	$ 0,045 (125,00%)	4,86M
CPICarlton Precious Inc	$ 0,16 (113,33%)	1 000
MVYMoovly Media Inc	$ 0,01 (100,00%)	1,5M
GAR.HGreen Arrow Resources Inc	$ 0,015 (-66,67%)	1,96k
CANDCandelaria Mining Corp	$ 0,005 (-50,00%)	553,7k
WWTWater Ways Technologies Inc	$ 0,005 (-50,00%)	79,65k
AZC.PA2ZCryptocap Inc	$ 0,045 (-50,00%)	33k
BYM.HBaymount Incorporated	$ 0,005 (-50,00%)	5k
FYLFinlay Minerals Ltd	$ 0,045 (125,00%)	4,86M
AGMRSilver Mountain Resources Inc	$ 0,05 (-9,09%)	4,23M
AHRAmarc Resources Ltd	$ 0,72 (171,70%)	4,17M
TDGTDG Gold Corp	$ 0,245 (75,00%)	4,08M
MATEBlockmate Ventures Inc	$ 0,33 (0,00%)	3,99M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Nervgen Pharma Corporation (NGEN)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

À propos de Nervgen Pharma Corporation

NGEN Dernières nouvelles

Life Science Investor Forum Agenda Announced for June 22nd

NervGen Pharma’s NVG-291-R Demonstrates Significant Functional Repair From a Stroke 7 Days After Onset in Landmark Preclinical Study by University of Cincinnati and Case Western Reserve University

NervGen Pharma Announces Intent to Conduct Groundbreaking Spinal Cord Injury Clinical Trial in Exclusive Partnership With Shirley Ryan AbilityLab, #1-Ranked Hospital in Physical Medicine & Rehabilitation

NervGen Pharma Corp. Announces Public Offering

American Stock Exchange to Trade Options on Four Securities

NGEN - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Nervgen Pharma Corporation (NGEN) Cours

Nervgen Pharma Corporation (NGEN)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

À propos de Nervgen Pharma Corporation

NGEN Dernières nouvelles

Life Science Investor Forum Agenda Announced for June 22nd

NervGen Pharma’s NVG-291-R Demonstrates Significant Functional Repair From a Stroke 7 Days After Onset in Landmark Preclinical Study by University of Cincinnati and Case Western Reserve University

NervGen Pharma Announces Intent to Conduct Groundbreaking Spinal Cord Injury Clinical Trial in Exclusive Partnership With Shirley Ryan AbilityLab, #1-Ranked Hospital in Physical Medicine & Rehabilitation

NervGen Pharma Corp. Announces Public Offering

American Stock Exchange to Trade Options on Four Securities

NGEN - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS